Skip to main content
Fig. 1 | BMC Pulmonary Medicine

Fig. 1

From: Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities

Fig. 1

a ECR response in the pooled ITT population, b patients meeting ECR criteria by visit in the pooled ITT population, and IACR success by visit in the pooled c mITT and d CE populations. CE clinically evaluable, ECR early clinical response, EOT end of treatment, IACR investigator assessment of clinical response, ITT intent to treat, LFU late follow-up, mITT modified ITT, TOC test of cure

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us